Tech Transfer Tidbits | GenomeWeb

Tech Transfer Tidbits

Premium

Battelle Ventures Invests $5M in MIT Drug-Discovery Outfit Hepregen

Battelle Ventures and its Tennessee-based affiliate, Innovation Valley Partners, said this week that they have committed to a $5 million Series A investment in Hepregen Corporation, a spinout of the Massachusetts Institute of Technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

Oct
13
Sponsored by
Personal Genome Diagnostics

This online seminar will discuss sample collection challenges associated with tumor sequencing, with a particular focus on somatic variant testing in plasma.